Cite
APA Citation
Coates, L., Kvien, T., Nash, P., Gossec, L., Strand, V., Pricop, L., Rasouliyan, L., Ding, K., Jugl, S., Gaillez, C., & , (n.d.). aB0772 Secukinumab provides sustained improvement in function, quality of life and fatigue over 2 years in patients who achieved low disease activity related to psoriatic arthritis disease activity score (PASDAS). Annals of the rheumatic diseases, 76, 1326. http://access.bl.uk/ark:/81055/vdc_100135153256.0x000060